×
Demographic Variables, Design Characteristics, and Effect Sizes of Randomized, Placebo-Controlled, Monotherapy Trials of Major Depressive Disorder and Bipolar Depression PDF
$ 40.00
Demographic Variables, Design Characteristics, and Effect Sizes of Randomized, Placebo-Controlled, Monotherapy Trials of Major Depressive Disorder and Bipolar Depression PDF quantity
$ 40.00
×
An Open-Label Study of the Treatment Efficacy of Olanzapine for Tourette's Disorder PDF
$ 40.00
An Open-Label Study of the Treatment Efficacy of Olanzapine for Tourette's Disorder PDF quantity
$ 40.00
×
Antidepressant Use and Lifetime History of Mental Disorders in a Community Sample: Results From the Baltimore Epidemiologic Catchment Area Study PDF
$ 40.00
Antidepressant Use and Lifetime History of Mental Disorders in a Community Sample: Results From the Baltimore Epidemiologic Catchment Area Study PDF quantity
$ 40.00
×
Role of Mirtazapine in the Pharmacotherapy of Depression PDF
$ 40.00
Role of Mirtazapine in the Pharmacotherapy of Depression PDF quantity
$ 40.00
×
Open-Label Trial of Escitalopram in the Treatment of Posttraumatic Stress Disorder PDF
$ 40.00
Open-Label Trial of Escitalopram in the Treatment of Posttraumatic Stress Disorder PDF quantity
$ 40.00
×
The Effects of Mirtazapine on Plasma Lipid Profiles in Healthy Subjects PDF
$ 40.00
The Effects of Mirtazapine on Plasma Lipid Profiles in Healthy Subjects PDF quantity
$ 40.00
×
A 1-Year Double-Blind Study of 2 Doses of Long-Acting Risperidone in Stable Patients With Schizophrenia or Schizoaffective Disorder. PDF
$ 40.00
A 1-Year Double-Blind Study of 2 Doses of Long-Acting Risperidone in Stable Patients With Schizophrenia or Schizoaffective Disorder. PDF quantity
$ 40.00
Coupon: Apply coupon
Update cart